These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2216047)
1. [HIV-correlated antigens and antibodies in patients treated with zidovudine]. Garavelli PL; Dallavalle FM Minerva Med; 1990; 81(7-8 Suppl):93-4. PubMed ID: 2216047 [TBL] [Abstract][Full Text] [Related]
2. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098 [TBL] [Abstract][Full Text] [Related]
3. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine. Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627 [TBL] [Abstract][Full Text] [Related]
4. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection]. Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560 [TBL] [Abstract][Full Text] [Related]
5. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection]. Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362 [TBL] [Abstract][Full Text] [Related]
6. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS]. de Gans J; Lange JM; Derix MM; de Wolf F; Ongerboer de Visser BW; Goudsmit J Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1656-60. PubMed ID: 3050555 [No Abstract] [Full Text] [Related]
7. [Diagnostico-prognostic significance of the analysis of anti-HIV antibodies and viral antigens in acquired immunodeficiency syndrome. Presentation of 2 paradigmatic cases]. Venturini L; Serpelloni G; Parolin A; Mezzelani P G Clin Med; 1989 May; 70(5):353-6. PubMed ID: 2753265 [TBL] [Abstract][Full Text] [Related]
8. Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients. Aidoo M; Nishiwaki O; Akari H; Brandful JA; Ampofo W; Hayami M; Ayisi NK West Afr J Med; 1994; 13(3):150-1. PubMed ID: 7841103 [TBL] [Abstract][Full Text] [Related]
9. Zidovudine treatment of AIDS and ARC in Denmark 1987. Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984 [TBL] [Abstract][Full Text] [Related]
10. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937 [TBL] [Abstract][Full Text] [Related]
11. [Long-term success with zidovudine in HIV infection]. Leber Magen Darm; 1989 May; 19(3):158. PubMed ID: 2500573 [No Abstract] [Full Text] [Related]
12. [Elevation of HIV-antigen concentration during administration of zidovudine]. Valencia ME; Gil A; Pintado V; Zapico RM Med Clin (Barc); 1993 Feb; 100(6):239. PubMed ID: 8429735 [No Abstract] [Full Text] [Related]
13. [Treatment of HIV infection with zidovudine. The good use of AZT]. Régnier B Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359 [No Abstract] [Full Text] [Related]
14. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report. Garavelli PL Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275 [No Abstract] [Full Text] [Related]
15. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome]. Schulte C; Meurer M; Fröschl M Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection. Cox PH; Martin MA; Styer CM; Beall GN Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666 [TBL] [Abstract][Full Text] [Related]
18. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. Rinaldo CR; Liebmann JM; Huang XL; Fan Z; Al-Shboul Q; McMahon DK; Day RD; Riddler SA; Mellors JW J Infect Dis; 1999 Feb; 179(2):329-36. PubMed ID: 9878015 [TBL] [Abstract][Full Text] [Related]
19. A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex. Gries JM; Troconiz IF; Verotta D; Jacobson M; Sheiner LB Clin Pharmacol Ther; 1997 Jan; 61(1):70-82. PubMed ID: 9024175 [TBL] [Abstract][Full Text] [Related]
20. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS. Reddy MM; McKinley G; Englard A; Grieco MH J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]